The genetic basis of variability in drug responses
Top Cited Papers
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 1 (1) , 37-44
- https://doi.org/10.1038/nrd705
Abstract
It is almost axiomatic that patients vary widely in their beneficial responses to drug therapy, and serious and apparently unpredictable adverse drug reactions continue to be a major public health problem. Here, we discuss the concept that genetic variants might determine much of this variability in drug response, and propose an algorithm to enable further evaluation of the benefits and pitfalls of this enticing possibility.Keywords
This publication has 71 references indexed in Scilit:
- Potential Role of Pharmacogenomics in Reducing Adverse Drug ReactionsJAMA, 2001
- Pharmacogenetics and adverse drug reactionsThe Lancet, 2000
- Pharmacogenetics and the practice of medicineNature, 2000
- Incidence and Costs of Adverse Drug Reactions During HospitalisationDrug Safety, 2000
- Pharmacogenomics: Translating Functional Genomics into Rational TherapeuticsScience, 1999
- Postmarketing Surveillance and Adverse Drug ReactionsPublished by American Medical Association (AMA) ,1999
- Polymorphisms of N-acetyltransferase genesXenobiotica, 1992
- Effect of Acetylator Phenotype on the Rate at Which Procainamide Induces Antinuclear Antibodies and the Lupus SyndromeNew England Journal of Medicine, 1978
- Genetic Control of Isoniazid Metabolism in ManBMJ, 1960
- Über die Erbbedingtheit der intraindividuellen Konstanz der Isoniazidausscheidung beim Menschen (Untersuchungen an eineiigen und zweieiigen Zwillingen)The Science of Nature, 1957